An antiviral drug candidate also known as GS-5734 developed by Gilead Sciences to treat Ebola virus that shows potential to treat coronavirus 2019-nCoV.
ambrisentan
brexucabtagene autoleucel
remdesivir
aztreonam for inhalation solution
axicabtagene ciloleucel
medicine
oseltamivir
adefovir dipivoxil
amphotericin B
sofosbuvir/velpatasvir
sacituzumab govitecan-hziy
Medication
ranolazine